La vendita allo scoperto per Peijia Medical dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Peijia Medical. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Peijia Medical (OTC:PEJMF) Azioni, Report sulle vendite allo scoperto

Peijia Medical Ltd is focused on the interventional procedural, transcatheter valve therapeutic, and the neurointerventional procedural medical device market in China. The company's product candidates include Transcatheter Aortic Valve Replacement products, Transcatheter Mitral Valve Replacement/Transcatheter Tricuspid Valve Replacement products, Ancillary products, Neurointerventional products, and its product pipeline consists of transcatheter valve therapeutic and neurointerventional products and product candidates. Its operating segments are Transcatheter Valve Therapeutic Business and Neurointerventional Business.

Peijia Medical Ltd

Stifel analyst Simon Yarmak maintains Travel+Leisure (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNL#NYSE">TNL</a>) with a Buy and raises the price target from $59 to $66.

News

Price Target

Analyst Ratings

Stifel Maintains Buy on Travel+Leisure, Raises Price Target to $66

Macro Economic Events

Econ #s

Economics

Reported Earlier: US Building Permits (Oct) 1.419M vs 1.416M Est. (Prior 1.425M)

WIIM

HSAI

Hesai Group shares are trading higher after the company reported better-than-expected Q3 sales results.

Stifel analyst Tore Svanberg maintains Semtech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMTC#NASDAQ">SMTC</a>) with a Buy and raises the price target from $58 to $65.

SMTC

Stifel Maintains Buy on Semtech, Raises Price Target to $65

Wells Fargo analyst Michael Turrin maintains Zoom Video Comms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) with a Underweight and raises the price target from $60 to $70.

Wells Fargo Maintains Underweight on Zoom Video Comms, Raises Price Target to $70

As of Nov. 26, 2024, three stocks in the industrials sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Woodward, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WWD#NASDAQ">WWD</a>)</h3>
<ul>
<li>On Nov. 25, Woodward reported better-than-expected quarterly EPS and sales. &#8220;We delivered record sales in fiscal 2024 with Woodward revenue exceeding $3 billion for the first time. Robust end market demand along with contributions from operational excellence fueled significant sales growth and earnings expansion,&#8221; said Chip Blankenship, Chairman and Chief Executive Officer. The company's stock gained around 5% over the past five days and has a <a href="https://www.benzinga.com/quote/WWD">52-week high of $188.34</a>.</li>
<li>RSI Value: 81.90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>WWD Price Action: Shares of Woodward gained 1.8% to close at $179.29 on Monday.</li>
</ul>
<h3 class="wp-block-heading">Aris Water Solutions Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARIS#NYSE">ARIS</a>)</h3>
<ul>
<li>On Nov. 4, Aris Water Solutions reported better-than-expected third-quarter financial results. &#8220;Aris had an exceptional third quarter as we continued to grow our produced water volumes, increased our recycled water sales, and maintained our strong margins. As we anticipated, our capital investment to support these increased activity levels was primarily deployed in the first half of the year and our capital spending in the third quarter declined significantly. We continue to experience steady volume growth and increasing cash generation,&#8221; said Amanda Brock, President and CEO of Aris. The company's stock gained around 79% over the past month and <a href="https://www.benzinga.com/quote/ARIS">has a 52-week high</a> of $27.64.</li>
<li>RSI Value: 80.45</li>
<li>ARIS Price Action: Shares of Aris Water Solutions gained 0.2% to close at $27.03 on Monday.</li>
</ul>
<h3 class="wp-block-heading">Mesa Air Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MESA#NASDAQ">MESA</a>)</h3>
<ul>
<li>On Oct. 16, Mesa Air Group reported a year-over-year decrease in third-quarter revenue results. The company's stock gained around 14% over the past five days and has a <a href="https://www.benzinga.com/quote/MESA">52-week high</a> of $1.89.</li>
<li>RSI Value: 74.27</li>
<li>MESA Price Action: Shares of Mesa Air gained 12.3% to close at $0.98 on Monday.</li>
</ul>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42174548/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

ARIS

MESA

Top 3 Industrials Stocks You May Want To Dump This Quarter

RDWR

Radware shares are trading higher after the company announced a relationship expansion with a top 10 India airport to deliver cloud applications and network security.

Stifel analyst Simon Yarmak maintains Marriott Vacations (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VAC#NYSE">VAC</a>) with a Buy and raises the price target from $102 to $112.

Stifel Maintains Buy on Marriott Vacations, Raises Price Target to $112

Wells Fargo analyst Aaron Rakers maintains Marvell Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRVL#NASDAQ">MRVL</a>) with a Overweight and raises the price target from $90 to $110.

MRVL

Wells Fargo Maintains Overweight on Marvell Tech, Raises Price Target to $110

RGTI

Rigetti Computing shares are trading lower. The company announced a registered direct offering of 50 million shares at $2 per unit.

Highlights ISS' Recognition of the Significant Progress Nano Has Made in Executing its Focused Value Creation Strategy and its Recommendation to Shareholders Vote FOR General (Ret.) Michael X. Garrett's Re-election
Disagrees with Other ISS Recommendations That Further Expand Murchinson's Board Representation and its Self-Serving Campaign to Paralyze Nano's Strategy
Nano Urges Shareholders to&nbsp;Vote "FOR" Re-election of CEO Yoav Stern and General (Ret.) Michael X. Garrett and ALL of Nano's Proposals
Deadline is Fast Approaching on Sunday, December 1, 2024, at 11:59 p.m. ET
Shareholders Should Vote as Soon as Possible to Ensure Their Vote is Counted

Biotech

General

NNDM

Nano Dimension Reiterates Calls For Shareholders To Vote "FOR" All Of Nano's Proposals; Disagrees With Other ISS Recommendations That Further Expand Murchinson's Board Representation And Its Self-Serving Campaign To Paralyze Nano's Strategy

Offerings

WLDS

Wearable Devices Ltd. Entered Securities Purchase Agreement With Institutional Investor For Issuance and Sale Of 822,000  Ordinary Shares In a Registered Direct Offering At Purchase Price Of $2.25 Per Share

Stifel analyst Simon Yarmak maintains Marriott Intl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MAR#NASDAQ">MAR</a>) with a Hold and raises the price target from $252 to $283.

Stifel Maintains Hold on Marriott Intl, Raises Price Target to $283

Insight Enterprises's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NSIT#NYSE">NSIT</a>) short percent of float has fallen 10.88% since its last report. The company recently reported that it has 1.43 million shares sold short, which is 10.08% of all regular shares that are available for trading. Based on its trading volume, it would take traders 5.54 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Insight Enterprises Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732626922_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Insight Enterprises has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing Insight Enterprises's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Insight Enterprises's peer group average for short interest as a percentage of float is 3.95%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

NSIT

(NSIT) - Analyzing Insight Enterprises's Short Interest

Humana's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUM#NYSE">HUM</a>) short percent of float has risen 15.92% since its last report. The company recently reported that it has 4.38 million shares sold short, which is 3.64% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.8 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>Humana Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732626916_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for Humana has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing Humana's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, Humana's peer group average for short interest as a percentage of float is 4.54%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

(HUM) - Analyzing Humana's Short Interest

United Therapeutics's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTHR#NYSE">UTHR</a>) short percent of float has risen 4.3% since its last report. The company recently reported that it has 2.30 million shares sold short, which is 6.79% of all regular shares that are available for trading. Based on its trading volume, it would take traders 6.06 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock/">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest">List of the most shorted stocks</a>
<h3>United Therapeutics Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1732626911_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for United Therapeutics has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing United Therapeutics's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://pro.benzinga.com/">Benzinga Pro</a>, United Therapeutics's peer group average for short interest as a percentage of float is 4.93%, which means the company has more short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze/">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

UTHR

How Is The Market Feeling About United Therapeutics?

JM Smucker shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 adjusted EPS guidance with its midpoint above estimates.

Stifel analyst Simon Yarmak maintains Hyatt Hotels (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/H#NYSE">H</a>) with a Hold and raises the price target from $145.5 to $157.5.

Stifel Maintains Hold on Hyatt Hotels, Raises Price Target to $157.5

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Deutsche Bank analyst Nicole Deblase downgraded Hubbell Incorporated (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HUBB#NYSE">HUBB</a>) from Buy to Hold and lowered the price target from $493 to $473. Hubbell shares closed at $463.86 on Monday. <a href="https://www.benzinga.com/quote/HUBB/analyst-ratings">See how other analysts view this stock.</a></li>
<li>HSBC analyst Saul Martinez downgraded the rating for The Goldman Sachs Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) from Buy to Hold but raised the price target from $569 to $608. Goldman Sachs shares closed at $603.03 on Monday. <a href="https://www.benzinga.com/quote/GS/analyst-ratings">See how other analysts view this stock.</a></li>
<li>Daiwa Capital analyst Kahori Tamada downgraded Target Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TGT#NYSE">TGT</a>) from Outperform to Neutral and announced a $130 price target. Target shares closed at $130.53 on Monday. <a href="https://www.benzinga.com/quote/PNW/analyst-ratings">See how other </a><a href="https://www.benzinga.com/quote/TGT/analyst-ratings">analysts </a><a href="https://www.benzinga.com/quote/PNW/analyst-ratings">view this stock.</a></li>
<li>HC Wainwright &amp; Co. analyst Vernon Bernardino downgraded the rating for Cassava Sciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SAVA#NASDAQ">SAVA</a>) from Buy to Neutral and announced a $116 price target. Cassava Sciences shares closed at $4.2950 on Monday. <a href="https://www.benzinga.com/quote/SAVA/analyst-ratings">See how other analysts view this stock.</a></li>
<li>DA Davidson analyst Kurt Yinger downgraded the rating for GMS Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) from Buy to Neutral and announced a $97 price target. GMS shares closed at $103.84 on Monday. <a href="https://www.benzinga.com/quote/GMS/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying GS stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="585" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26081046/image-279-1024x585.png" alt="" class="wp-image-665305" style="width:675px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26081046/image-279-1024x585.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26081046/image-279-300x172.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26081046/image-279-768x439.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/26081046/image-279.png 1102w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42174548/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>

Downgrades

HUBB

SAVA

This Goldman Sachs Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

U.S. stock futures were slightly higher this morning, with the Nasdaq futures gaining around 0.1% on Tuesday.
Shares of Leslie&#8217;s, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LESL#NASDAQ">LESL</a>) fell sharply in today's pre-market trading after the company reported worse-than-expected fourth-quarter <a href="https://www.benzinga.com/news/earnings/24/11/42176455/leslies-stock-drops-after-q4-results-heres-why">adjusted EPS and sales</a>.
Leslie's reported quarterly earnings of two cents per share which missed the analyst consensus estimate of 11 cents. Quarterly revenue came in at $397.9 million which missed the analyst consensus estimate of $405.19 million and is a decrease from sales of $432.37 million from the same period last year.
Leslie&#8217;s shares dipped 18.5% to $2.86 &nbsp;in the pre-market trading session.
Here are some other stocks moving lower in pre-market trading.
<ul>
<li>Alector, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALEC#NASDAQ">ALEC</a>) shares tumbled 31.3% to $2.72 in pre-market trading after the company announced that the INVOKE-2 Phase 2 clinical trial evaluating the safety and efficacy of AL002 in individuals with early Alzheimer&#8217;s disease failed to meet its primary endpoint.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KC#NASDAQ">KC</a>) shares dipped 10.5% to $6.22 in pre-market trading.</li>
<li>Agora, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/API#NASDAQ">API</a>) fell 8.8% to $4.34 in pre-market trading following third-quarter results.</li>
<li>Quantum Computing Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QUBT#NASDAQ">QUBT</a>) shares fell 8.6% to $7.04 in pre-market trading. Quantum Computing shares jumped around 26% on Monday after AWS announced Quantum Embark program.</li>
<li>Zoom Video Communications, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZM#NASDAQ">ZM</a>) fell 7.8% to $82.02 in today's pre-market trading. Zoom Video posted better-than-expected results for its third quarter and raised its guidance for the full year.</li>
<li>Blue Bird Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBD#NASDAQ">BLBD</a>) shares declined 7.8% to $39.48 in pre-market trading after the company reported mixed fourth-quarter financial results and issued FY25 revenue guidance below estimates..</li>
<li>Biglari Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BH#NYSE">BH</a>) shares fell 3.2% to $200.40 in pre-market trading.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/11/42174548/jim-cramer-says-this-stock-is-a-bitcoin-play-and-he-prefers-to-own-bitcoin">Jim Cramer Says This Stock Is A Bitcoin Play And He Prefers To Own Bitcoin</a></li>
</ul>

Comments

Peijia Medical

Vendite allo scoperto

Peijia Medical (OTC:PEJMF) Azioni, Report sulle vendite allo scoperto

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO